Biochemical and pharmacological characterization of the human lymphocyte antigen B-associated transcript 5 (BAT5/ABHD16A).
<h4>Background</h4>Human lymphocyte antigen B-associated transcript 5 (BAT5, also known as ABHD16A) is a poorly characterized 63 kDa protein belonging to the α/β-hydrolase domain (ABHD) containing family of metabolic serine hydrolases. Its natural substrates and biochemical properties ar...
Guardado en:
Autores principales: | Juha R Savinainen, Jayendra Z Patel, Teija Parkkari, Dina Navia-Paldanius, Joona J T Marjamaa, Tuomo Laitinen, Tapio Nevalainen, Jarmo T Laitinen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7badfbd1be224b0b86ab6594956a58a2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Discovery of triterpenoids as reversible inhibitors of α/β-hydrolase domain containing 12 (ABHD12).
por: Teija Parkkari, et al.
Publicado: (2014) -
Macrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRM
por: Hongming Miao, et al.
Publicado: (2016) -
ABHD5 blunts the sensitivity of colorectal cancer to fluorouracil via promoting autophagic uracil yield
por: Juanjuan Ou, et al.
Publicado: (2019) - Biochemical pharmacology
-
ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation
por: Yan Gu, et al.
Publicado: (2021)